Articles From: Bing shares the top searches of 2014 to Bioanalytical Systems to Release Fourth Quarter Fiscal 2014 Results on Wednesday December 17, 2014; Conference Call & Webcast Set For 11:00 a.m. EST


2014/11/30
Bing outlines the people, moments and events that shaped 2014 at http://www.BingTrends.com. REDMOND, Wash.
Sign-up for Bing shares the top searches of 2014 investment picks
2014/12/1
Bing's Top Search Terms of 2014 Outline the Highs and Lows of the Year Canada NewsWire Bing outlines the people, moments, and events that shaped 2014 for Canadians TORONTO , Dec.
Sign-up for Bing's Top Search Terms of 2014 Outline the Highs and Lows of the Year investment picks
TEL AVIV, Israel, Nov.
Sign-up for Bio Blast Pharma Reports Third Quarter Financial Results investment picks
Bio-Path Holdings, Inc., (NASDAQ:BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced the appointment of Amy P.
Sign-up for Bio-Path Holdings Appoints Amy P. Sing, M.D. to its Board of Directors investment picks
Bio-Path Holdings, Inc., (NASDAQ:BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced operational and financial results for the third quarter ended September 30, 2014.
Sign-up for Bio-Path Holdings Reports Third Quarter 2014 Operational and Financial Results investment picks
Bio-Path Holdings, Inc., (NASDAQ:BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that it has successfully completed Cohort 6 of its Phase I clinical trial evaluating lead compound, Liposomal Grb-2, in blood cancers.
Sign-up for Bio-Path Holdings Successfully Completes Cohort 6 of Phase I Clinical Trial Evaluating Liposomal Grb-2 in Blood Cancers investment picks
Bio-Path Holdings, Inc., (NASDAQ:BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that Peter Nielsen, President and Chief Executive Officer, will present a company overview at the 13 th Annual BIO Investor Forum Conference in San Francisco on Tuesday, October 7, 2014 at 10:00 a.m. Pacific Time (1:00pm Eastern Time). The overview will include an update on Cohort 6 of the Phase I clinical trial evaluating Grb-2 in blood cancers, in which the last patient in the cohort has been treated and is evaluable.
Sign-up for Bio-Path Holdings to Present at the 13th Annual BIO Investor Forum investment picks
http://media.marketwire.com/attachments/201308/181926_BIO-RADLOGO.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1148697&ProfileId=051205&sourceType=1 HERCULES, CA --
Sign-up for Bio-Rad Appoints John Goetz as Chief Operating Officer and Announces Other Executive Appointments investment picks
http://media.marketwire.com/attachments/201308/181926_BIO-RADLOGO.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1155901&ProfileId=051205&sourceType=1 HERCULES, CA --
Sign-up for Bio-Rad Laboratories Resolves Foreign Corrupt Practices Act Matters With U.S. Government investment picks
http://media.marketwire.com/attachments/201308/181926_BIO-RADLOGO.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1159948&ProfileId=051205&sourceType=1 HERCULES, CA --
Sign-up for Bio-Rad Receives Premarket Application Approval for Its Geenius HIV 1/2 Supplemental Assay investment picks
http://media.marketwire.com/attachments/201308/181926_BIO-RADLOGO.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1156358&ProfileId=051205&sourceType=1 HERCULES, CA --
Sign-up for Bio-Rad Reports Third-Quarter 2014 Financial Results investment picks
http://media.marketwire.com/attachments/201308/181926_BIO-RADLOGO.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1150372&ProfileId=051205&sourceType=1 HERCULES, CA --
Sign-up for Bio-Rad to Report Third-Quarter 2014 Financial Results Tuesday, November 4, 2014 investment picks
MINNEAPOLIS , Nov.
Sign-up for Bio-Techne Announces Agreement To Acquire CyVek investment picks
MINNEAPOLIS , Oct.
Sign-up for Bio-Techne Declares Dividend investment picks
MINNEAPOLIS , Oct.
Sign-up for Bio-Techne Releases First Quarter Fiscal 2015 Results investment picks
MINNEAPOLIS, MN , Nov.
Sign-up for BioAmber Reports Third Quarter 2014 Financial Results investment picks
5 year supply agreement is with Xuchuan Chemical, a global leader in polyester polyols BioAmber bio-succinic acid will initially be used to produce cast polyurethane elastomers (CPU). Other applications for BioAmber succinic acid include resins for shoe soles and synthetic leathers Xuchuan operates 4 production facilities in China , with a total capacity of 150,000 tons per year The market opportunity for bio-succinic acid at Xuchuan is several thousand tons per year MONTREAL , Oct.
Sign-up for BioAmber Signs Exclusive Supply Agreement for Bio-Succinic Acid investment picks
BioAmber Signs Exclusive Supply Agreement for Bio-Succinic Acid in Lubricants Canada NewsWire 5 year supply agreement is with Oleon, a European leader in oleochemicals BioAmber bio-succinic acid is being used to produce bio-based lubricants Oleon is developing lubricants offering high performance, biodegradability and bio-based content Oleon operates 5 manufacturing facilities: four in Europe and one in Malaysia The addressable market for succinic acid in specialty lubricants is estimated to be $100 million MINNEAPOLIS , Dec.
Sign-up for BioAmber Signs Exclusive Supply Agreement for Bio-Succinic Acid in Lubricants investment picks
5 year supply agreement is with Oleon, a European leader in oleochemicals BioAmber bio-succinic acid is being used to produce bio-based lubricants Oleon is developing lubricants offering high performance, biodegradability and bio-based content Oleon operates 5 manufacturing facilities: four in Europe and one in Malaysia The addressable market for succinic acid in specialty lubricants is estimated to be $100 million MINNEAPOLIS , Dec.
Sign-up for BioAmber Signs Exclusive Supply Agreement for Bio-Succinic Acid in Lubricants investment picks
BioAmber to Announce Third Quarter 2014 Financial Results on November 6, 2014 Canada NewsWire Minneapolis, MN , Oct.
Sign-up for BioAmber to Announce Third Quarter 2014 Financial Results on November 6, 2014 investment picks
Minneapolis, MN , Oct.
Sign-up for BioAmber to Announce Third Quarter 2014 Financial Results on November 6, 2014 investment picks
Bioanalytical Systems, Inc. (NASDAQ:BASI) will release financial results for the fourth quarter of fiscal 2014 ended September 30, 2014 at approximately 8:30 a.m. EST on Wednesday, December 17, 2014.
Sign-up for Bioanalytical Systems to Release Fourth Quarter Fiscal 2014 Results on Wednesday December 17, 2014; Conference Call & Webcast Set For 11:00 a.m. EST investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Bing shares the top searches of 2014 to Bioanalytical Systems to Release Fourth Quarter Fiscal 2014 Results on Wednesday December 17, 2014; Conference Call & Webcast Set For 11:00 a.m. EST
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent